DK1713805T3 - Kinaseinhibitorer - Google Patents

Kinaseinhibitorer

Info

Publication number
DK1713805T3
DK1713805T3 DK05704878T DK05704878T DK1713805T3 DK 1713805 T3 DK1713805 T3 DK 1713805T3 DK 05704878 T DK05704878 T DK 05704878T DK 05704878 T DK05704878 T DK 05704878T DK 1713805 T3 DK1713805 T3 DK 1713805T3
Authority
DK
Denmark
Prior art keywords
kinase inhibitors
kinase
inhibitors
Prior art date
Application number
DK05704878T
Other languages
Danish (da)
English (en)
Inventor
Rosanne Bonjouklian
Chafiq Hamdouchi
Chuan Shih
Dios Alfonso De
Prado Miriam Filadelfa Del
Aguado Carlos Jaramillo
Pramila Kotiyan
Mary Margaret Mader
Sheila Pleite Selgas
Concepcion Sanchez-Martinez
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34837430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1713805(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK1713805T3 publication Critical patent/DK1713805T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK05704878T 2004-01-30 2005-01-25 Kinaseinhibitorer DK1713805T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54083004P 2004-01-30 2004-01-30
PCT/US2005/000025 WO2005075478A1 (fr) 2004-01-30 2005-01-25 Inhibiteurs de kinases

Publications (1)

Publication Number Publication Date
DK1713805T3 true DK1713805T3 (da) 2009-08-17

Family

ID=34837430

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05704878T DK1713805T3 (da) 2004-01-30 2005-01-25 Kinaseinhibitorer

Country Status (26)

Country Link
US (2) US7582652B2 (fr)
EP (1) EP1713805B1 (fr)
CN (1) CN100516064C (fr)
AR (1) AR047466A1 (fr)
AT (1) ATE433449T1 (fr)
AU (1) AU2005210459B2 (fr)
CA (1) CA2559128C (fr)
CY (1) CY1109234T1 (fr)
DE (1) DE602005014848D1 (fr)
DK (1) DK1713805T3 (fr)
DO (1) DOP2005000010A (fr)
ES (1) ES2326819T3 (fr)
HK (1) HK1100141A1 (fr)
IL (1) IL178103A (fr)
MY (1) MY143516A (fr)
NZ (1) NZ549780A (fr)
PE (1) PE20050689A1 (fr)
PL (1) PL1713805T3 (fr)
PT (1) PT1713805E (fr)
RU (1) RU2348635C2 (fr)
SI (1) SI1713805T1 (fr)
SV (1) SV2006002001A (fr)
TW (1) TWI332003B (fr)
UA (1) UA85505C2 (fr)
WO (1) WO2005075478A1 (fr)
ZA (1) ZA200607648B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI332003B (en) * 2004-01-30 2010-10-21 Lilly Co Eli Kinase inhibitors
US7776869B2 (en) * 2004-10-18 2010-08-17 Amgen Inc. Heteroaryl-substituted alkyne compounds and method of use
EP1992344A1 (fr) 2007-05-18 2008-11-19 Institut Curie P38 alpha comme cible therapeutique pour les maladies associées á une mutation de FGFR3
CN103068824B (zh) * 2010-05-17 2017-09-08 印蔻真治疗公司 作为蛋白激酶调节剂的新型3,5‑二取代‑3h‑咪唑并[4,5‑b]吡啶和3,5‑二取代‑3h‑[1,2,3]三唑并[4,5‑b]吡啶化合物
TWI410425B (zh) * 2010-12-03 2013-10-01 Lilly Co Eli 唑并［５，４－ｂ］吡啶－５－基化合物
CA2850559C (fr) * 2011-11-11 2016-11-29 Eli Lilly And Company Polytherapie utilisee pour le cancer de l'ovaire
CN104640918A (zh) * 2012-07-23 2015-05-20 阿克伦大学 含有有机改性蒙脱石的基于聚异丁烯的聚氨酯
TWI731317B (zh) 2013-12-10 2021-06-21 美商健臻公司 原肌球蛋白相關之激酶（ｔｒｋ）抑制劑
CN107231803B (zh) 2014-12-18 2019-12-03 建新公司 原肌球蛋白相关激酶(trk)抑制剂的药物制剂
MA41179A (fr) 2014-12-19 2017-10-24 Cancer Research Tech Ltd Composés inhibiteurs de parg
MY186133A (en) 2015-03-02 2021-06-24 Rigel Pharmaceuticals Inc Tgf-? inhibitors
WO2019071147A1 (fr) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. Inhibiteurs de la kinase p38 réduisant l'expression du gène dux4 et des gènes aval pour le traitement de la fshd
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
US10899869B2 (en) 2019-01-24 2021-01-26 The University Of Akron Glycerol containing polyurethanes and polyurethane nanocomposites
TW202112368A (zh) 2019-06-13 2021-04-01 荷蘭商法西歐知識產權股份有限公司 用於治療有關dux4表現之疾病的抑制劑組合

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9300141A (es) * 1992-01-13 1994-07-29 Smithkline Beecham Corp Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
DE19503806A1 (de) * 1994-02-11 1995-08-17 Bernhardt Apparatebau Gmbh Co Vorrichtung zum Aufblasen eines Behälters oder eines Schwimmkörpers, insbesondere einer Schwimmweste
US6426360B1 (en) * 1994-07-28 2002-07-30 G D Searle & Co. 4,5-substituted imidazolyl compounds for the treatment of inflammation
US5620999A (en) 1994-07-28 1997-04-15 Weier; Richard M. Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
US5717100A (en) * 1995-10-06 1998-02-10 Merck & Co., Inc. Substituted imidazoles having anti-cancer and cytokine inhibitory activity
WO1998007425A1 (fr) * 1996-08-21 1998-02-26 Smithkline Beecham Corporation Composes d'imidazole, compositions les contenant et leur utilisation
US6087496A (en) * 1998-05-22 2000-07-11 G. D. Searle & Co. Substituted pyrazoles suitable as p38 kinase inhibitors
US6180632B1 (en) * 1997-05-28 2001-01-30 Aventis Pharmaceuticals Products Inc. Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
AU8167398A (en) 1997-06-30 1999-01-19 Temple University - Of The Commonwealth System Of Higher Education Method for treating vulvar vestibulitis
AR016294A1 (es) * 1997-07-02 2001-07-04 Smithkline Beecham Corp Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion
WO1999032121A1 (fr) * 1997-12-19 1999-07-01 Smithkline Beecham Corporation .0mposes d'imidazole heteroaryle substitues, leurs compositions et usages pharmaceutiques
US6207687B1 (en) 1998-07-31 2001-03-27 Merck & Co., Inc. Substituted imidazoles having cytokine inhibitory activity
US6291457B1 (en) 1999-07-01 2001-09-18 Merck & Co., Inc. Compounds having cytokine inhibitory activity
WO2001030778A1 (fr) * 1999-10-27 2001-05-03 Novartis Ag Composes thiazole et imidazo [4,5-b] pyridine et leur utilisation pharmaceutique
GB0007405D0 (en) 2000-03-27 2000-05-17 Smithkline Beecham Corp Compounds
MXPA03008144A (es) 2001-03-09 2003-12-12 Pfizer Prod Inc Nuevos compuestos antiinflamatorios de triazolopiridinas.
HUP0303829A3 (en) 2001-04-16 2006-02-28 Tanabe Seiyaku Co Large conductance calcium-acitvated k channel opener compounds, use thereof and pharmaceutical compositions containing them
CA2474322A1 (fr) 2002-01-25 2003-07-31 Kylix Pharmaceuticals B.V. (thia-/oxa-/pyra) zoles substitues 4(hetero-) aryle pour inhibition de tie-2
EP1537112B1 (fr) 2002-08-06 2006-04-19 Astrazeneca AB Pyridines condensees et pyrimidines a activite tie2 (tek)
TWI332003B (en) * 2004-01-30 2010-10-21 Lilly Co Eli Kinase inhibitors

Also Published As

Publication number Publication date
PE20050689A1 (es) 2005-09-27
ATE433449T1 (de) 2009-06-15
DE602005014848D1 (de) 2009-07-23
US20090036445A1 (en) 2009-02-05
EP1713805A1 (fr) 2006-10-25
CY1109234T1 (el) 2014-07-02
AU2005210459B2 (en) 2010-10-21
PT1713805E (pt) 2009-08-20
WO2005075478A1 (fr) 2005-08-18
SV2006002001A (es) 2006-02-15
IL178103A (en) 2011-04-28
CA2559128C (fr) 2013-04-16
TWI332003B (en) 2010-10-21
EP1713805B1 (fr) 2009-06-10
DOP2005000010A (es) 2005-11-15
RU2348635C2 (ru) 2009-03-10
ZA200607648B (en) 2008-06-25
AU2005210459A1 (en) 2005-08-18
HK1100141A1 (en) 2007-09-07
ES2326819T3 (es) 2009-10-20
RU2006138606A (ru) 2008-05-10
NZ549780A (en) 2010-01-29
AR047466A1 (es) 2006-01-18
PL1713805T3 (pl) 2009-10-30
MY143516A (en) 2011-05-31
TW200526660A (en) 2005-08-16
SI1713805T1 (sl) 2009-10-31
CA2559128A1 (fr) 2005-08-18
UA85505C2 (en) 2009-01-26
CN1938302A (zh) 2007-03-28
US20090318443A1 (en) 2009-12-24
CN100516064C (zh) 2009-07-22
US7582652B2 (en) 2009-09-01

Similar Documents

Publication Publication Date Title
DK1704145T3 (da) Selektive kinaseinhibitorer
ATE433449T1 (de) Kinaseinhibitoren
ATE520671T1 (de) Pyrimidin-harnstoff-derivate als kinase-hemmer
ATE493403T1 (de) Kinaseinhibitoren
EP1794137A4 (fr) Inhibiteurs de kinases specifiques
ATE505471T1 (de) Azaindol-kinaseinhibitoren
DK1979356T3 (da) Carbonylaminopyrrolopyrazoler, kraftige kinaseinhibitorer
DK2253614T3 (da) IAP-inhibitorer
DK1778718T3 (da) Iap-inhibitorer
ZA200606683B (en) Pyrazolotriazines as kinase inhibitors
IL190078A0 (en) Kinase inhibitors
DK2099447T3 (da) Imidazotriaziner og imidazopyrimidiner som kinaseinhibitorer
DK1809978T3 (da) Modul-skydebane
IL183276A0 (en) Kinase inhibitors
BRPI0716781A2 (pt) Inibidores da quinase
DE602004018837D1 (de) Ptidase-iv-inhibitoren
ATE545642T1 (de) Mmp-inhibitoren
DK2013175T5 (da) p38 Map-kinase-inhibitorer
DK2035385T3 (da) Inhibitorer af akt (proteinkinase B)
ATE520664T1 (de) Tyrosinkinase-hemmer
ITMI20041626A1 (it) Inibitori della chinurenina-ammino-trasferasi
BRPI0719883A2 (pt) Inibidores de quinase
FR2865904B1 (fr) Calecon remonte fesses
DE602005008061D1 (de) Kinaseinhibitoren
DE602006019301D1 (de) Kinaseinhibitoren